Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

PACS Group, Inc. (PACS) SEC Filings & Earnings Calls

EquiReason read 20 PACS Group, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-21 — Chief Legal Officer John Mitchell retired; Patrick J. Murphy appointed as successor; Mitchell to serve as consultant for up to 12 months with severance..

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PACSPACS Group, Inc.Follow PACS — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
7.5B
P/E TTM
27.9
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

21 Sep 20268-K · 5.02, 7.01Chief Legal Officer John Mitchell retired; Patrick J. Murphy appointed as successor; Mitchell to serve as consultant for up to 12 months with severance.SEC ↗
4 Aug 202610-QPACS reported strong Q2 2026 results with revenue up 9.1% YoY, net income up 49.8%, and same-store occupancy improving 150 bps.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$1.43B+9% y/y
Net income · Q2-2026$76M+50% y/y
Adjusted EBITDA · Q2-2026$167M+25% y/y
Occupancy rate (operational beds) · Total skilled nursing · Q2-202690.4%
Skilled nursing services revenue · Total skilled nursing · Q2-2026$1.38B+8% y/y
Skilled mix by revenue · Total skilled nursing · Q2-202650.0%
Number of facilities · Total post-acute care · Q2-2026324+3% y/y
Operating cash flow · H1-2026$372M+83% y/y

Risks flagged

Regulatory and compliance risk

“The SNF industry is highly regulated with stringent regulatory compliance obligations.” · word for word

Liability insurance cost increase

“increase in liability insurance of $26.2 million” · word for word

Legal and investigation costs

“Legal and other costs 8,167 24,060 19,944 46,864” · word for word
Read the original on SEC EDGAR ↗
4 Aug 20268-K · 2.02Revenue $1.43B (+9% y/y); Net income $76M (+50% y/y); Adjusted EBITDA $167M (+25% y/y); Guidance: FY2026 Adjusted EBITDA $640-$660M (from $605-$625M); Revenue $5.75-$5.85B (from $5.65-$5.75B)earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$1.43B+9% y/y
Net income · Q2-2026$76M+50% y/y
Adjusted EBITDA · Q2-2026$167M+25% y/y

Guidance

FY2026 Adjusted EBITDA $640-$660M (from $605-$625M); Revenue $5.75-$5.85B (from $5.65-$5.75B)

Raised full-year guidance across revenue and EBITDA, reflecting strong operational performance and acquisition pipeline.

Risks flagged

Regulatory and reimbursement risks in skilled nursing industry.

“Industry average occupancy 79.5% vs company 90.4%; regulatory environment.”
Read the original on SEC EDGAR ↗
11 May 202610-QRevenue $1.42B (+11% y/y); Net Income $81M (+184% y/y); Adjusted EBITDA $170M (+75% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$1.42B+11% y/y
Net Income · Q1-2026$81M+184% y/y
Adjusted EBITDA · Q1-2026$170M+75% y/y
Occupancy · Q1-202690.8%
Skilled Mix by Revenue · Q1-202650.7%
Operating Cash Flow · Q1-2026$236M+57% y/y

Risks flagged

Regulatory and Compliance Risk

“The SNF industry is highly regulated with stringent regulatory compliance obligations.” · word for word

Credit Facility Covenant Risk

“We entered into forbearance agreements and amendments to the Amended and Restated Credit Facility due to technical events of default.”

California Concentration Risk

“Our California operations represent our largest geographic concentration, comprising 140 facilities and 16,132 beds/units, or approximately 43% and 45%, respectively, of our total facilities and beds/units.” · word for word

Labor Cost Pressure

“Cost of services increased by $50.7 million, primarily driven by an increase of $39.5 million, or 6.2%, in salaries and wages.”
Read the original on SEC EDGAR ↗
11 May 20268-K · 2.02Revenue $1.42B (+11% y/y); Net income $81M (+184% y/y); Adjusted EBITDA $170M (+75% y/y); Guidance: Full-year 2026 Adj. EBITDA guidance raised to $605-625M from $555-575Mearningsopen

Figures in the filing · each found in the filing text

Revenue · Q1-2026$1.42B+11% y/y
Net income · Q1-2026$81M+184% y/y
Adjusted EBITDA · Q1-2026$170M+75% y/y
Occupancy · Q1-202690.8%
Skilled mix · Q1-202630.5%
Cash provided by operating activities · Q1-2026$236M

Guidance

Full-year 2026 Adj. EBITDA guidance raised to $605-625M from $555-575M

Strong Q1 beat drives upward revision to full-year EBITDA guidance.

Risks flagged

Guidance excludes future acquisitions, which may limit growth visibility.

“updated guidance excludes contributions from future acquisitions” · word for word

WQIP payments of $16.3M are non-recurring in nature.

“includes approximately $16.3 million of net EBITDA benefit from payments received under California’s Workforce & Quality Incentive Program” · word for word
Read the original on SEC EDGAR ↗
28 Apr 2026DEF 14AProxy statement with strong financial performance, executive compensation disclosure, and clawback recovery details.open

Figures in the filing · each found in the filing text

Net Income · FY2025$191M
Adjusted EBITDA · FY2025$505M
Total Shareholder Return · FY2025$167.00
Compensation Actually Paid to PEO · FY2025$18M
Average Compensation Actually Paid to non-PEO NEOs · FY2025$22M

Risks flagged

Financial Restatement Risk

“The Audit Committee conducted an independent internal investigation of third-party allegations contained in a short-seller report published in November 2024.” · word for word

Controlled Company Governance Risk

“We are a 'controlled company' under the rules of the NYSE. As of the Record Date, Messrs. Murray and Hancock beneficially own approximately 70% of the combined voting power of our outstanding capital stock.” · word for word
Read the original on SEC EDGAR ↗
27 Apr 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open

Risks flagged

CFO transition risk, mitigated by planned succession and experienced appointee.

“CFO change with interim period ending.”
Read the original on SEC EDGAR ↗
5 Mar 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)SEC ↗
27 Feb 202610-KNumber of Facilities 321; Daily Patient Census 31,700; Occupancy Rate (Mature Facilities) 95open

Figures in the filing · each found in the filing text

Number of Facilities · FY2025321
Daily Patient Census · FY202531,700
Occupancy Rate (Mature Facilities) · Mature · FY202595.0%
QM Star Rating (Mature Facilities) · Mature · FY2025$4.40+2% y/y
Skilled Mix by Nursing Patient Days · FY202529.0%
Number of Employees · FY202547,455

Risks flagged

Reimbursement Risk from Government Payors

“We depend upon reimbursement from third‑party payors, and our revenue, financial condition and results of operations could be negatively impacted by any changes in the acuity mix of patients in our facilities as well as changes in payor mix and payment methodologies.” · word for word

Labor Shortage and Wage Inflation

“Increased competition for, or a shortage of, nurses, nurse assistants and other skilled personnel could increase our staffing and labor costs and subject us to monetary fines.” · word for word

Regulatory Compliance and Enforcement

“Our policy is to comply with laws prohibiting kickbacks and referral payments to referral sources. If our competitors use more aggressive methods than we do with respect to obtaining patient referrals, our competitors may from time to time obtain patient referrals that are not otherwise available to us.” · word for word
Read the original on SEC EDGAR ↗
26 Feb 20268-K · 2.02Revenue $5.29B (+29% y/y); Net income $192M; Adjusted EBITDA $505M; Guidance: 2026 revenue $5.65-5.75B, EBITDA $555-575Mearningsopen

Figures in the filing · each found in the filing text

Revenue · FY2025$5.29B+29% y/y
Net income · FY2025$192M
Adjusted EBITDA · FY2025$505M
Mature facilities occupancy · Skilled Nursing · FY202594.9%
Mature facilities skilled mix · Skilled Nursing · FY202533.4%
Cash provided by operating activities · FY2025$404M

Guidance

2026 revenue $5.65-5.75B, EBITDA $555-575M

Guidance implies continued growth driven by acquisitions and occupancy.

Read the original on SEC EDGAR ↗
1 Dec 20258-K · 1.01Minimum cash covenant $100Mopen

Figures in the filing · each found in the filing text

minimum cash covenant · Q4-2025$100M

Risks flagged

Default waiver and covenant modification indicate elevated financial risk and potential liquidity constraints.

“Waived all defaults and events of default; cash covenant modified to only apply until June 30, 2026.” · word for word
Read the original on SEC EDGAR ↗
25 Nov 2025DEF 14APACS Group filed a DEF 14A proxy statement disclosing executive compensation tied to Adjusted EBITDA, a financial restatement triggering clawback of $3.84M, and high insider ownership.open

Figures in the filing · each found in the filing text

Net income · FY2024$55M-51% y/y
Adjusted EBITDA · FY2024$280M+18% y/y
Total Shareholder Return · 2024-04-11 to 20$57.00
Peer Group Total Shareholder Return · 2024-04-11 to 20$116.06
Shares Outstanding · 2025-11-10156,615,444

Risks flagged

Financial Restatement Risk

“the Audit Committee determined that (i) our condensed combined/consolidated financial statements as of March 31, 2024, and for the three months then ended, included in our Quarterly Report on Form 10-Q filed with the SEC on May 13, 2024 (as amended on May 21, 2024) and (ii) our condensed combined/consolidated financial statements as of June 30, 2024, should ” · word for word

Insider Control Risk

“All Executive Officers and Directors as a Group (8 individuals) 110,320,631 70.4%” · word for word

Clawback Enforcement Risk

“the aggregate amount that remains outstanding is $1,227,019. ... The Compensation Committee will seek to recover the remaining amount of the erroneously awarded compensation from each of Messrs. Murray and Hancock in accordance with the Clawback Policy.” · word for word
Read the original on SEC EDGAR ↗
19 Nov 20258-K · 2.02Revenue $1.34B (+31% y/y); Net income $52M; Adjusted EBITDA $132M; Guidance: FY2025 revenue $5.25-5.35B, Adj. EBITDA $480-490Mearningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$1.34B+31% y/y
Net income · Q3-2025$52M
Adjusted EBITDA · Q3-2025$132M
Adjusted EBITDAR · Q3-2025$227M
Revenue · YTD-2025$3.93B+36% y/y
Net income · YTD-2025$132M
Adjusted EBITDA · YTD-2025$363M
Adjusted EBITDAR · YTD-2025$646M
Revenue · FY2024$4.09B+31% y/y
Net income · FY2024$55M

Guidance

FY2025 revenue $5.25-5.35B, Adj. EBITDA $480-490M

Guidance raised for FY2025 reflecting strong demand and operational execution.

Risks flagged

Restatement and investigation completed, but prior accounting issues may indicate control weaknesses.

“Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations. Audit Committee completes investigation.” · word for word
Read the original on SEC EDGAR ↗
19 Nov 202510-QPACS reported strong revenue growth of 39.9% YoY and net income of $51M vs a loss last year, but disclosed credit facility forbearance and rising legal costs.earningsopen

Figures in the filing · each found in the filing text

Skilled mix by revenue · Total · Q2-202549.4%
Occupancy rate (operational beds) · Total · Q2-202588.6%
Adjusted EBITDA · Q2-2025$134M+115% y/y
Net income · Q2-2025$51M+260% y/y
Operating cash flow · H1-2025$203M+117% y/y

Risks flagged

Credit facility forbearance and technical defaults

“We are in a state of forbearance with the lenders associated with the Amended and Restated Credit Facility and as a result, we are currently unable to borrow additional amounts.” · word for word

Legal and regulatory investigations

“Legal and other costs include legal and professional fees incurred associated with the Audit Committee’s independent investigation and with other ongoing investigations.” · word for word

Occupancy decline in new and ramping facilities

“New and Ramping facilities experienced a decrease in occupancy, from 84.2% and 94.4%, respectively, for the three months ended June 30, 2024 to 80.5% and 86.1%, respectively, for the three months ended June 30, 2025” · word for word
Read the original on SEC EDGAR ↗
19 Nov 202510-Q9M 2025 earnings: revenue +36.4% YoY, net income +587.5% YoY, but credit facility in forbearance and legal costs elevated.earningsopen

Figures in the filing · each found in the filing text

Occupancy rate (operational beds) · 9M-202588.9%
Skilled mix by revenue · 9M-202549.1%
Net income · 9M-2025$132M+588% y/y
Adjusted EBITDA · 9M-2025$363M+96% y/y
Operating cash flow · 9M-2025$408M+35% y/y

Risks flagged

Credit facility forbearance and technical defaults

“During the forbearance period, we are required to comply with certain additional specified conditions, including the continued maintenance of minimum liquidity of $100 million, limitations on certain investments and acquisitions, and a prohibition on the borrowing of new loans under the Amended and Restated Credit Facility.” · word for word

Government investigations and legal costs

“Legal and other costs 66,460 for the nine months ended September 30, 2025.”

Medicaid funding cuts under OBBBA

“The OBBBA imposes significant reductions in the funding of the Medicaid program, such reductions are expected to decrease the number of persons enrolled in Medicaid and reduce the services covered by Medicaid.” · word for word
Read the original on SEC EDGAR ↗
19 Nov 202510-QQ3 2025 earnings: revenue +31% YoY, net income +223% YoY, but credit facility in forbearance and legal costs elevated.earningsopen

Figures in the filing · each found in the filing text

Occupancy rate (operational beds) · Q3-202589.0%
Skilled mix by revenue · Q3-202548.0%
Net income · Q3-2025$52M+223% y/y
Adjusted EBITDA · Q3-2025$132M+168% y/y
Operating cash flow · 9M-2025$408M+35% y/y

Risks flagged

Credit facility forbearance and technical defaults

“During the forbearance period, we are required to comply with certain additional specified conditions, including the continued maintenance of minimum liquidity of $100 million, limitations on certain investments and acquisitions, and a prohibition on the borrowing of new loans under the Amended and Restated Credit Facility.” · word for word

Government investigations and legal costs

“Legal and other costs 19,596 for the three months ended September 30, 2025.”

Medicaid funding cuts under OBBBA

“The OBBBA imposes significant reductions in the funding of the Medicaid program, such reductions are expected to decrease the number of persons enrolled in Medicaid and reduce the services covered by Medicaid.”
Read the original on SEC EDGAR ↗
19 Nov 202510-QPACS reported strong revenue growth of 38.8% YoY but net income declined 18.5% due to rising legal costs, and disclosed credit facility forbearance.earningsopen

Figures in the filing · each found in the filing text

Skilled mix by revenue · Total · Q1-202550.0%
Occupancy rate (operational beds) · Total · Q1-202589.2%
Adjusted EBITDA · Q1-2025$98M+32% y/y
Net income · Q1-2025$28M-19% y/y
Operating cash flow · Q1-2025$150M+156% y/y

Risks flagged

Credit facility forbearance and technical defaults

“We are in a state of forbearance with the lenders associated with the Amended and Restated Credit Facility and as a result, we are currently unable to borrow additional amounts.” · word for word

Legal and regulatory investigations

“Legal and other costs include legal and professional fees incurred associated with the Audit Committee’s independent investigation and with other ongoing investigations.” · word for word

Occupancy decline in new and ramping facilities

“New facilities experienced a slight decrease in occupancy, from 83.3% for the three months ended March 31, 2024 to 81.8% for the three months ended March 31, 2025” · word for word
Read the original on SEC EDGAR ↗
19 Nov 202510-KRevenue $4.10B (+32% y/y); Net Income $55M (-51% y/y); Adjusted EBITDA $280M (+18% y/y)open

Figures in the filing · each found in the filing text

Revenue · Consolidated · FY2024$4.10B+32% y/y
Net Income · Consolidated · FY2024$55M-51% y/y
Adjusted EBITDA · Consolidated · FY2024$280M+18% y/y
Occupancy Rate (Mature) · Mature Facilities · FY202494.0%
Occupancy Rate (Overall) · Consolidated · FY202490.0%
QM Star Rating (Mature) · Mature Facilities · FY2024$4.30+2% y/y
Skilled Mix by Revenue (Mature) · Mature Facilities · FY202454.0%
Skilled Mix by Nursing Patient Days · Consolidated · FY202429.0%
Number of Facilities · Consolidated · FY2024314
Number of Employees · Consolidated · FY202445,680

Risks flagged

Dependence on government reimbursement

“A substantial portion of our revenue is generated from payments from third-party payors, including Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.8% and 40.4% of our routine revenue for the year ended December 31, 2024, respectively.” · word for word

Regulatory compliance and enforcement risk

“We operate in a highly regulated industry with stringent regulatory compliance obligations, which require robust regulatory compliance operations. Failure to operate in compliance with applicable laws and regulations could require significant expenditures and result in regulatory deficiencies and other regulatory penalties.” · word for word
Read the original on SEC EDGAR ↗
17 Nov 2025NT 10-QTold the SEC its quarterly report (10-Q) will be filed lateSEC ↗
6 Nov 20258-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement)open

Risks flagged

Delisting risk from NYSE due to delinquent filings.

“NYSE deadline November 19, 2025; company not current.”

Forbearance extension indicates potential covenant breach or default.

“Forbearance agreement with lenders and landlord extended to Nov 30, 2025.”

Ongoing Audit Committee investigation may reveal further issues.

“Risks relating to ongoing Audit Committee investigation.”
Read the original on SEC EDGAR ↗

PACS Group, Inc. — questions

What did PACS Group, Inc. file recently?
20 SEC filings in the last 12 months. Latest: 8-K on 2026-09-21 — Chief Legal Officer John Mitchell retired; Patrick J. Murphy appointed as successor; Mitchell to serve as consultant for up to 12 months with severance.

Every figure on this page comes from PACS Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.